71 research outputs found
SeptiFast Real-Time PCR for Detection of Bloodborne Pathogens in Patients with Severe Sepsis or Septic Shock
Several studies have been performed investigating the role of a real-time multiplex polymerase chain reaction assay LightCycler® SeptiFast® with inconsistent results. In prospective evaluation of adult patients with severe sepsis or septic shock SeptiFast assay and blood culture results were compared regarding concordance, the impact of SeptiFast assay on antimicrobial therapy adjustment, time to results and the role of SeptiFast assay as a marker of disease severity. 63 blood sample sets were collected from 57 patients. 51 (80.9%) results were concordant negative and 7 (11.1%) concordant positive. In one (1.6%) sample set blood culture was positive and SeptiFast assay negative, in three (4.8%) sample sets with negative blood cultures pathogens were detected by SeptiFast assay and in one (1.6%) patient an additional pathogen was detected by SeptiFast assay. If blood culture is considered as „gold standard“, 1 (1.6%) SeptiFast false negative and 4 (6.3%) false positive results were identified (sensitivity 87.5%, specificity 92.6%, negative predictive value 97.8%). Antibiotic treatment was adjusted according to SeptiFast assay in 4 (6.3%) cases. Time to final results was significantly shorter with SeptiFast assay (32 ± 23 h vs. 97 ± 28 h, p<0.0001). Positive SeptiFast assay was not associated with higher mortality, C-reactive protein or procalcitonin (p=0.74, p=0.44 and p=0.12, respectively). According to our results SeptiFast assay can be used as a valuable add-on to blood culture in diagnostic workup of patients with severe sepsis and septic shock but it cannot replace the blood culture
Clinical Features and Virologic Characteristics of Primary and Early HIV-1 Infection in Slovenian Patients
Analysis of time trends in newly diagnosed HIV-1 infected patients in Slovenia over a 10-year period (1996-2005)
showed an increase in the number of newly diagnosed HIV-1 infected patients in 2004 and 2005 as well as increase in the
number of newly diagnosed patients with primary/early HIV-1 infection. A retrospective analysis was performed in order
to evaluate the clinical, epidemiological, laboratory and virological parameters of primary/early HIV-1 infection presenting
with or without acute retroviral syndrome (ARS). Primary/early HIV-1 infection was diagnosed in 33 (19.5%) out of
169 newly diagnosed HIV-1 infected patients during the 10-year period. Most patients experienced ARS, the most commonly
reported symptoms being fever, malaise and pharyngitis, followed by rash and lymphadenopathy. Median CD4
cell count was 415 cells/mm3, median CD8 cell count was 865 cells/mm3 and median HIV-1 viral load at the time of diagnosis
was 5.1 log10 copies/mL. The increase in the number of newly diagnosed HIV-1 infected patients may be in part due
to increased awareness among clinicians of the possibility of ARS, and the possibility of increased awareness of symptoms
of ARS among persons at high risk of infection
HIV-1 Subtype B Epidemic and Transmission Patterns in Slovenia
In the present study the epidemic of human immunodeficiency virus type 1 (HIV-1) subtype B in Slovenia during the
10-year period was investigated using phylogenetic analysis of pol gene sequences. 119 pol sequences generated on samples
dated from January 1996 to December 2005 were retrieved from the database of Slovenian HIV/AIDS Reference Laboratory.
The phylogenetic analysis revealed 14 potentially significant transmission clusters (bootstrap value 98%),
comprising 34 HIV-1 strains. The vast majority of clustered individuals were men (91%), and of them, 79% were men
who have sex with men. Factors significantly associated with clustering were: recent infection (HIV-1 infection during or
after year 2003), diagnosis of primary HIV-1 infection, higher CD4 cell count and acquiring HIV-1 infection in Slovenia.
Recent subtype B HIV-1 infections are the important driving force of current HIV-1 epidemic in Slovenia
Molecular characterization of human papillomavirus type 159 (HPV159)
Human papillomavirus type 159 (HPV159) was identified in an anal swab sample and preliminarily genetically characterized by our group in 2012. Here we present a detailed molecular in silico analysis that showed that the HPV159 viral genome is 7443 bp in length and divided into five early and two late genes, with conserved functional domains and motifs, and a non-coding long control region (LCR) with significant regulatory sequences that allow the virus to complete its life cycle and infect novel host cells. HPV159, clustering into the cutaneotropic Betapapillomavirus (Beta-PV) genus, is phylogenetically most similar to HPV9, forming an individual phylogenetic group in the viral species Beta-2. After testing a large representative collection of clinical samples with HPV159 type-specific RT-PCR, in addition to the anal canal from which the first HPV159 isolate was obtained, HPV159 was further detected in other muco-cutaneous (4/181, 2.2%), mucosal (22/764, 2.9%), and cutaneous (14/554, 2.5%) clinical samples, suggesting its extensive tissue tropism. However, because very low HPV159 viral loads were estimated in the majority of positive samples, it seemed that HPV159 mainly caused clinically insignificant infections of the skin and mucosa. Using newly developed, highly sensitive HPV159-specific nested PCRs, two additional HPV159 LCR viral variants were identified. Nevertheless, all HPV159 mutations were demonstrated outside important functional domains of the LCR, suggesting that the HPV159 viral variants were most probably not pathogenically different. This complete molecular characterization of HPV159 enhances our knowledge of the genome characteristics, tissue tropism, and phylogenetic diversity of Beta-PVs that infect humans
False-Positive Result of a Confirmatory Human Immunodeficiency Virus Line Immuno Assay in an Apparently Healthy Individual – A Case Report
A case of a false-positive result of human immunodeficiency virus (HIV) confirmatory immunoblot-based assay is described.
Repeatedly borderline reactive anti-HIV screening enzyme immunoassay result obtained in a local hospital resulted
in directing the sample to the Slovenian HIV/AIDS Reference Laboratory. In the Reference Laboratory, both anti-
HIV screening assays and confirmatory Western blot were negative, while a confirmatory test INNO-LIA HIV I/II Score
(Innogenetics, Ghent, Belgium) was anti-HIV-1 positive due to sgp120 and gp41 reactivity. The results of serological testing
of the second sample obtained three weeks later were completely identical, while in the third sample obtained 5
months later, seroreversion was observed. Due to a negative dynamics in anti-HIV serological profile and repeatedly negative
results of the molecular tests for HIV-1 and HIV-2, HIV infection was excluded and the results of test INNO-LIA
HIV I/II Score were finally interpreted as false positive
Blood-Stained Letter Received by HIV/AIDS Reference Laboratory in 1993 – A Historical Case Report
We describe an interesting historical case of a blood-stained letter received in 1993 by Slovenian HIV/AIDS Reference
Laboratory. According to the statement of the sender, the letter was spotted with HIV-infected blood. The polymerase
chain reaction (PCR) amplification with two gag and env primer sets excluded the presence of HIV proviral DNA in the
spot punches obtained from the dried blood spots. Although the presence of HIV DNA was confirmed in 5 positive control
blood spots using the same sets of primers, we still doubted in the accuracy of the HIV negative result. Fortunately, we obtained
a serum sample of the author of the letter four months later from a psychiatric institution where he was hospitalized
for paranoid schizophrenia. Since no anti HIV-1/2 antibodies were detected in his serum sample, our initial HIV
negative findings based on PCR testing of blood spots were confirmed
Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates
Objectives The first hospital outbreak of carbapenemase-producing Enterobacteriaceae in Slovenia occurred in 2014-2016. Whole genome sequencing was used to analyse the population of carbapenem-resistant Klebsiella pneumoniae collected in Slovenia in 2014-2017, including OXA-48 and/or NDM-1 producing strains from the outbreak. Methods A total of 32 K. pneumoniae isolates were analysed using short-read sequencing. Multilocus sequence typing and core genome multi-locus sequence typing were used to infer genetic relatedness. Antimicrobial resistance markers, virulence factors, plasmid content and wzi types were determined. Long-read sequencing was used for six isolates for detailed analysis of plasmids and their possible transmission. Results Overall, we detected 10 different sequence types (STs), the most common being ST437 (40.6%). Isolates from the initial outbreak belonged to ST437 (12/16) and ST147 (4/16). A second outbreak of four ST15 isolates was discovered. A new ST (ST3390) and two new wzi types (wzi-556, wzi-559) were identified. blaOXA-48 was found in 17 (53.1%) isolates, blaNDM-1 in five (15.6%), and a combination of blaOXA-48/NDM-1 in seven (21.9%) isolates. Identical plasmids carrying blaOXA-48 were found in outbreak isolates sequenced with long-read sequencing technology. Conclusions Whole genome sequencing of Slovenian carbapenem-resistant K. pneumoniae isolates revealed multiple clusters of STs, two of which were involved in the first hospital outbreak of carbapenem producing K. pneumoniae in Slovenia. Transmission of the plasmid carrying blaOXA-48 between two STs was likely to have occurred. A previously unidentified second outbreak was also discovered, highlighting the importance of whole genome sequencing in detection and/or characterization of hospital outbreaks and surveillance of drug-resistant bacterial clones
- …